What is a women-focused TB diagnostic support service in India?

A B2B2C service model that trains gender-sensitive diagnostic counsellors, embeds them in clinics/TB centres, and provides reproductive health TB screening (targeting subfertility and menstrual irregularity as TB symptoms). It includes peer support groups and transport assistance. It bridges India's diagnosis gap for women: 40–50% of female TB cases are late-diagnosed or misdiagnosed due to stigma and gender-blind protocols.

How much does it cost to start this service in India?

MVP startup cost: ₹35–50 lakh. Breakdown: Counsellor training & certification ₹12 lakh, diagnostic protocol development ₹8 lakh, support platform & call centre ₹10 lakh, working capital ₹8 lakh. Scales to ₹1.2–1.5 crore for multi-state rollout across 5 districts within 18 months.

Is this service profitable in India?

Yes. At scale (5,000 women screened/month): ₹50–100 lakh/month from diagnostic fees + ₹5–8 lakh/quarter from government contracts + ₹60–100 lakh/month from support subscriptions = ₹1.8–3 crore annual revenue. Gross margin: 55–65%. Payback period: 14–18 months. Demand is acute: India's TB burden in women is rising 3–5% YoY, and government prioritizes gender-responsive care post-2019 framework.

What regulations apply to this service in India?

RNTCP (NTEP rules) mandates trained counsellors for TB diagnosis; Ministry of Health's 2019 Gender-Responsive TB Framework sets standards. ICMR diagnostic guidelines govern reproductive TB screening. GST: 5% on diagnostic services, 12% on software. DPSP Act 2023 governs patient data privacy. State TB Officer approval required. Peer support and financial aid (transport vouchers) fall under NRLM/PMJDY if registered as social enterprise.

Women TB Diagnostic Support Service India 2026 Guide

AI SummaryIndia's TB burden in women is ₹9,600 lakh cases annually (35% of 27.4 lakh total), with 40–50% facing late or incorrect diagnosis due to gender-blind screening, stigma, and reproductive health blind spots. A women-focused TB diagnostic service network—embedding trained counsellors in clinics, screening for reproductive TB symptoms (subfertility, irregular menses), and providing peer/financial support—addresses a ₹8,500–12,000 crore market gap. With India's government having formalized a Gender-Responsive TB Framework (2019) and the TB Mukt Bharat scheme expanding service contracts, timing is right in 2026 for social enterprises and health entrepreneurs to scale. Target: NGOs, healthcare operators, and impact investors in high-burden states (Maharashtra, Karnataka, Tamil Nadu, Uttar Pradesh).